Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats

Angiogenesis

Volumn 16, Issue 4, 2013, Pages 773-784

  Kang, Kyu Tae ^a,b   Coggins, Matthew ^c   Xiao, Chunyang ^c   Rosenzweig, Anthony ^c   Bischoff, Joyce ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Duksung Women's University   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Cardiac function; ECFC; Ischemic myocardium; MPC

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENDOTHELIAL COLONY FORMING CELL; ENDOTHELIUM CELL; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART WEIGHT; HUMAN; HUMAN CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALIA; RATTUS;

ADULT; ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEASIBILITY STUDIES; GENES, REPORTER; HEMATOPOIETIC STEM CELLS; HEMODYNAMICS; HETEROGRAFTS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROVESSELS; MYOCARDIAL REPERFUSION INJURY; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, NUDE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84884813284     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9354-9     Document Type: Article

References (41)

1. Roger VL, Go AS, et al. (2012) Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125(1):188-197
2. Cao F, Lin S, et al. (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113(7):1005-1014
3. Bifari F, Pacelli L, Krampera M (2010) Immunological properties of embryonic and adult stem cells. World J Stem Cells 2(3):50-60
4. Kamihata H, Matsubara H, et al. (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104(9):1046-1052
5. Dohmann HF, Perin EC, et al. (2005) Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation 112(4):521-526
6. Traverse JH, Henry TD, et al. (2012) Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 308(22):2380-2389
7. Traverse JH, Henry TD, et al. (2011) Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 306(19):2110-2119
8. Silva GV, Litovsky S, et al. (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111(2):150-156
9. Wara AK, Croce K, et al. (2011) Bone marrow-derived CMPs and GMPs represent highly functional proangiogenic cells: implications for ischemic cardiovascular disease. Blood 118(24):6461-6464
10. Kawamoto A, Gwon HC, et al. (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103(5):634-637
11. Yeh ET, Zhang S, et al. (2003) Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108(17):2070-2073
12. Losordo DW, Schatz RA, et al. (2007) Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 115(25):3165-3172
13. Ii M, Horii M, et al. (2011) Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart. Lab Invest 91(4):539-552
14. Katare R, Riu F, et al. (2011) Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 109(8):894-906
15. Li TS, Cheng K, et al. (2012) Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59(10):942-953
16. Makkar RR, Smith RR, et al. (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379(9819):895-904
17. Bolli R, Chugh AR, et al. (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378(9806):1847-1857
18. Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110(4):624-637
19. Melero-Martin JM, De Obaldia ME, et al. (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103(2):194-202
20. Foubert P, Matrone G, et al. (2008) Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res 103(7):751-760
21. Kang KT, Allen P, Bischoff J (2011) Bioengineered human vascular networks transplanted into secondary mice reconnect with the host vasculature and re-establish perfusion. Blood 118(25):6718-6721
22. Melero-Martin JM, Khan ZA, et al. (2007) In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109(11):4761-4768
23. Allen P, Melero-Martin J, Bischoff J (2011) Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. J Tissue Eng Regen Med 5(4):e74-e86
24. Melero-Martin JM, Bischoff J (2008) Chapter 13. An in vivo experimental model for postnatal vasculogenesis. Methods Enzymol 445:303-329
25. Matsui T, Tao J, et al. (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104(3):330-335
26. Wu JC, Cao F, et al. (2006) Proteomic analysis of reporter genes for molecular imaging of transplanted embryonic stem cells. Proteomics 6(23):6234-6249
27. Lang RM, Bierig M, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440-1463
28. Das S, Aiba T, et al. (2012) Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation 126(18):2208-2219
29. Au P, Tam J, Fukumura D, Jain RK (2008) Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111(9):4551-4558
30. Chen X, Aledia AS, et al. (2009) Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A 15(6):1363-1371
31. Chen X, Aledia AS, et al. (2010) Rapid anastomosis of endothelial progenitor cell-derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts. Tissue Eng Part A 16(2):585-594
32. White SM, Hingorani R, et al. (2012) Longitudinal in vivo imaging to assess blood flow and oxygenation in implantable engineered tissues. Tissue Eng Part C Methods 18(9):697-709
33. Henry TD, Annex BH, et al. (2003) The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107(10):1359-1365
34. Laham RJ, Chronos NA, et al. (2000) Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. J Am Coll Cardiol 36(7):2132-2139
35. Lin YD, Luo CY, et al. (2012) Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair. Sci Transl Med 4(146):146ra109
36. Paul A, Chen G, et al. (2012) Genipin-crosslinked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction. Cell Transpl 21(12):2735-2751
37. Konoplyannikov M, Haider KH, et al. (2012) Activation of diverse signaling pathways by ex vivo delivery of multiple cytokines for myocardial repair. Stem Cells Dev 22(2):204-215
38. Kreutziger KL, Muskheli V, et al. (2011) Developing vasculature and stroma in engineered human myocardium. Tissue Eng Part A 17(9-10):1219-1228
39. Chong JJ (2012) Cell therapy for left ventricular dysfunction: an overview for cardiac clinicians. Heart Lung Circ 21(9):532-542
40. Vilahur G, Juan-Babot O, et al. (2011) Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J Mol Cell Cardiol 50(3):522-533
41. Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190(3):255-266